SlideShare a Scribd company logo
MICROBIAL DISEASE OF
THE CENTRAL NERVOUS
SYSTMEM
CENTRAL NERVOUS SYSTEM
• The Central Nervous System (CNS) consists of the
brain, which protected by the skull bones, and the
spinal cord, which is protected by the backbone.
• The CNS is covered by three layer of membranes
called meninges: the dura mater, arachnoid mater,
and pia mater. Cerebrospinal fluid (CSF) circulates
between the arachnoid mater and pia mater in the
subarachnoid space.
• Microorganisms can enter the CNS through trauma,
along peripheral nerves, and through the
bloodstream and lymhatic system
BACTERIAL DISEASES
Bacterial Meningitis
Tetanus
Botulism
Leprosy
BACTERIAL MENINGITIS
a. Haemophilus influenzae Meningitis
Causative Agent: Haemophilus influnzae-
an aerobic, gram negative bacteria
that is a common member of the normal throat
microbiota.
Mode of transmission: transmitted from person
to person through respiratory droplet spread. It
may also be rarely acquired through contact with
infected respiratory discharge.
Pathophysiology:The bacterial organisms replicate and undergo lysis in the CSF, releasing
endotoxin or cell wall fragment. These substances initiate the release of inflammatory
mediators, which set the stagefor a complex but coordinated sequence of events by which
neutrophils binds to cerebral endothelial cells by the release of toxic oxygen products,
permitting fluid to move across the capillary wall
Presenting signs and symptoms: a triad fever, chills, headache, stiff neck, nausea and vomiting.
Eventually meningitis progress to convulsion and coma.
AntimicrobialTreatment:Broad spectrum third generation cephalosporins are usually the first
choice of antibiotics; some experts recommend including vancomycin
NursingIntervention:
>Rapid IV fluid replacement
>Protect the patient from injury secondary to seizure activity or altered level of consciousness
>Reduce high fever to decrease load of the heart and brain from oxygen demand
> Maintain head or neck in midline position, provide small pillow to support
BACTERIAL MENINGITIS
B. Neisseria Meningitis(MeningococcalMeningitis)
CausativeAgent:Nesseria meningitides- an aerobic,
gram negative bacterium with a polysaccharidecapsule
that is importantto its virulence.
Mode of transmission: transmitted from person to
person through droplets of respiratory or throat
secretion from carriers.
Pathophysiology: A bacterium penetrates the blood
brain barrier. Endotoxin binds to plasma endotoxin
binding protein and to the cellular receptor, CD14 and
other cellular receptors triggering an intense
inflammatory response. Activated macrophagesproduce
a rangeof proinflammatorycytokines the concentration
of severity of disease.
Presenting Signs and Symptoms: stiff neck, high fever, sensitivity to light, confusion,
headache, and vomiting.
Antimicrobial treatment: Range of antibiotics can treat the infection, including
penicillin, ampicillin, and ceftriaxone.
Nursing Interventon:
>Monitor daily body weigh
>Initiate seizure precautions
>Elevate the head of the bed 30 degrees, and avoid neck flexion and extreme hip
flexion
>Rapid IV replacement
BACTERIAL MENINGITIS
C. Streptococcus pneumonie Meningitis
Causative Agent: Streptococcus pneumonie- gram positive,
encapsulated diplococcus.
Mode of transmission: transmitted through direct contact
with tiny droplets from an infected person’smouth, throat or
nose.
Pathophysiology: during the invasive disease, pneumococcal
epithelial adhesion is followed by bloodstream invasion and
activation of the complement and coagulation systems. The
release of inflammatory mediators facilitates pnemococcal
crossing of the blood barrier into the brain, where the
bacteria multiply freely and triggered activation of circulating
antigen presenting cell and resident microglial cell. The
resulting massive inflammation leads to further neutrophil
recruitment and inflammation, resulting in the well-known
features of bacterial meningitis.
PresentingSignsand Symptoms: Fever, drowsiness, impaired consciousness, severe headache,
vomiting, stiff neck and pain moving the neck
AntimicrobialTreatment: Dexamethasone has been shown to be beneficial as adjunct therapy
in the treatment of pneumococcal meningitis if administered 15 to 20 minutes before the first
dose of antibiotic and every 6 hours for the next 4 days.research suggestthat dexamethasone
improves the outcome in adults and does not increase the risk for gastrointestinalbleeding.
NursingIntervention:
>Ensuring close neurologic monitoring
>Encourage patient to stay hydrated either orally or peripherally
>Protect the patient from injury secondary to seizure activity or altered level of consciousness
>Assisting getting rest in a quiet, darkened room
>Monitoring daily body weight; serum electrolytes; and urine volume, specific gravity and
osmolality; especially if syndrome of inappropriateantidiuretic hormone is suspected.
TETANUS
Causative Agent: Clostridum tetani
obligately anaerobic, endospore forming,
gram positive rod.
It is especially common in soil
contaminated with animal fecal waste.
advance case of tetanus
Mode of transmission: spores get into the
body through broken skin, usually through
injuries from contaminated objects. Certain
breaks in the skin are more likely to get
infected with tetanus bacteria.
Pathophysiology:when tetanus toxin is taken up into nerve terminals of lower motor neurons,
the nerve cells that activatevoluntary muscle. Tetanus toxin is a zinc metalloproteinasethat
targetprotein that is necessary for the release of neurotransmitter from nerve endings through
fusion of synaptic vesicles with the neuronal plasma membrane. The initial symptoms of local
tetanus infection may therefore flaccid paralysis, caused by interference with vesicular release
of acetylcholine at the neuromuscular junction, as occur in butulinum toxin. However, unlike
botulinum toxin, tetanus toxin undergoes extensive retrogradetransport in axons of lower
motor neurons and thus reaches the spinal cord or brainstem. Here the toxin is transported
across synapses and taken up by nerve endings ihibitiory GABA ergic and gylnergic neurons that
control the activity of the lower neurons. Once inside inhibitory nerve terminals, tetanus toxn
cleaves VAMP,thereby inhibiting the release GABA and glycine. The result is a partial, functional
denervation of the lower motor neurons which lead to their hyperactivity and to increased
muscle activity and in the form of rigidity and spasms.
PresentingSignsand Symptoms:Spasms and stiffness in your jaw muscles, stiffness in the neck
muscles, difficulty swallowing, Fever, Elevating Blood pPressure and rapid heart rate.
Antimicrobial Treatment:Administer Human TIG 500 units by intramuscular injection or intravenously as
soon as possible; in addition administer age appropriate TT-containingvaccine, 0.5 cc by intramuscular
injection. Metronidole is preferred,penicillin G, tertracyclines, macrolides, clindamycin, cephalosporins
and chloramphenicol are also effective;
Nursing Intervention:
>Protect the client from injury
>Monitor for signs and symptoms of arrhythmias
>Preventclient from having spasms by:
-controllingthe environment
-avoiding stress, pain, coughing or flatus to ccur in patient
-avoid touching, turning and jarring the bed of the client
>Maintain adequate airway and ventillation
LEPROSY
Causative Agent: Mycobacterium leprae
the first bacterium to be identified as
causing disease in humans.
Mode of Transmission: spread person to
person by nasal secretions or droplets.
They speculate that infected droplets
reach other peoples' nasal passages and
begin the infection there.
Pathophysiology:microorganismthat has a predilection for the skin and nerves. M. leprae
primarily infects Schwann cells in the peripheral nerves leading to nerve damageand the
development of disabilities. Despite reduced prevalenceof M. leprae infection in the endemic
countries following implementation of multidrug therapy (MDT) program by WHO to treat
leprosy, new case detection rates are still high-indicating active transmission. The susceptibility
to the mycobacteria and the clinical course of the disease are attributed to the host immune
response, which heralds the review of immunopathology of this complex disease.
PresentingSignand Symptoms:Early symptoms begin in cooler areas of the
body and include loss of sensation. Signs of leprosy are painless ulcers,
skin lesions of hypopigmented macules (flat, pale areas of skin)
, and eye damage(dryness, reduced blinking).
AntimicrobialTreatment:The first-line drugs are dapsone, rifampin, and clofazimine. ... Second-
line agents include minocycline, ofloxacin, and clarithromycin,which can be used to treat a
single skin lesion or to treat patients with dapsone allergy.
Nursing Intervention
>Diagnose the impaired tissue integrity and monitor the characteristics of the lesion
such as size, color, odor and drainage.
>Clean the wounds with saline or nontoxic substances as indicated.
>Apply sterile bandage to cover the wounds and maintain aseptic technique
>Examine the wound damage daily during each dressing changes.
⦁ Routinely monitor temperature and color of skin.
VIRAL DISEASES
Poliomyelitis
Rabies
Arboviral Encephalitis
POLIOMYELITIS
Causative Agent: human
enterovirus and member of the
family of Picornaviridae.
Mode of transmission: Polio
viruses are spread predominantly
by the fecal–oral route.
Pathophysiology:The virus enters via the fecal-oral or respiratory route, then enters the
lymphoid tissues of the GI tract. A primary (minor) viremia follows with spread of virus to the
reticuloendothelial system. Infection may be contained at this point, or the virus may further
multiply and cause several days of secondary viremia, culminating in the development of
symptoms and antibodies.
In paralytic infections, poliovirus enters the CNS—whether via secondary viremia or via
migration up peripheral nerves is unclear. Significant damageoccurs in only the spinal cord and
brain, particularly in the nerves controlling motor and autonomic function. Inflammation
compounds the damageproduced by primary viral invasion. Factors predisposing to serious
neurologic damageinclude Increasingage (throughout life),Recent tonsillectomy or
intramuscular injection, pregnancy,impairment of B-cell function, and physical exertion
concurrentwith onset of the CNS phase.
PRESENTING SIGN AND SYMPTOMS: which can last up to 10 days, include fever, sore throat,
headache, vomiting, fatigue, back pain or stiffness, neck pain, stiffness in the arms or legs,
muscle weakness or tenderness
ANTIMICROBIAL TREATMENTS:No drug can kill the virus once an infection has begun. Treatment is
directed at controllingthe symptoms of the disease. People with minor poliomyelitis are treated
with bed rest and over-the-counter medicines to control fever and muscle aches.
People with major poliomyelitis may requireadditional treatments, including Physical therapy,
Measures to preventurinary tract infections, Mechanical breathing support
NURSING INTERVETION:
>Maintain a patent airway, and keep a tracheotomy tray at the patient’s bed side.
>Encouragea return to mild activity as soon as possible.
>Preventfecal impaction by giving enough fluids to ensurean adequate daily urine output of low
specific gravity.
>Provide good skin care, re-position the patient often, and keep bed linens dry.
>To alleviate discomforts, use foam rubberpads and sandbags or light splints as ordered.
>Wash hands thoroughly after contact with the patient or any of his secretions and excretions.
RABIES
Causative Agent: Rabies virus, a member of
genus lyssavirus having a characteristic of bullet
shape. Lyssavirus are single stranded RNA viruses
with no proofreading capability and mutant
strains develop rapidly.
Mode of Transmission: The most
common mode of rabies virus transmissionis
through the bite and virus-containing saliva of an
infected host. Though transmission has been
rarely documented via other routes such as
contamination of mucous membranes (i.e., eyes,
nose, mouth), aerosoltransmission, and corneal
and organ transplantations.
PresentingSignand Symptoms: Paresthesia, pain, or intense itching at the inoculation site is
pathognomonic for rabies and occurs in 50% of cases during this phase; this may be the
individual's only presenting sign. Symptoms may include the following: Malaise.
AntimicrobialTreatment: Rabies shots include: A fast-acting shot (rabies immune globulin) to
prevent the virus from infecting you. Part of this injection is given near the area where the
animal bit you if possible, as soon as possible after the bite.
NursingIntervention:
>Isolate the patient
>Give emotional and spiritual support
>Darken the room and prove a quiet environment
>Patient should not be bathed and there should not be any running water in the room or within
the hearing distance of the patient.
>If IV fluid has to be given it should be wrapped and needle should be securely anchored in the
vein to avoid dislodging in times of restlessness
ARBOVIRAL ENCEPHALITIS
CausativeAgent: Arthropod-borne viruses
(arboviruses) are of paramount concern as a group
of pathogens at the forefront of emerging and re-
emerging diseases. Here, we
discuss arboviruses from diverse families
(Flaviviruses, Alphaviruses, and the Bunyaviridae)
that are causativeagents of encephalitis in humans
Mode of Transmission: Arboviral encephalitis:
Inflammation of the brain (encephalitis) caused by
infection with an arbovirus, a virus transmitted by a
mosquito, tick or another arthropod. Infection of
vertebrates, including humans, occurs when an
infected arthropod feasts upon them for a blood
meal.
Pathophysiology: Arthropod-borneviruses(arboviruses) are of paramount concern as a group of pathogens
at the forefrontof emerging and re-emerging diseases. Although some arboviral infections are asymptomatic
or presentwith a mild influenza-like illness, many are important human and veterinary pathogens causing
serious illness ranging fromrash and arthritis to encephalitis and hemorrhagic fever. Here, we discuss
arbovirusesfrom diverse families (Flaviviruses, Alphaviruses, and the Bunyaviridae) that are causative agents
of encephalitis in humans. An understandingof the natural history of these infections as well as shared
mechanisms of neuroinvasion and neurovirulenceis critical to controlthe spread of these viruses and for the
developmentof effective vaccines and treatment modalities.
Presenting Sign and Symptoms:Headache, Feeling unwell, Drowsiness,Fever,Vomiting, Stiff neck, Muscle
sorenessor trembling, Confusion,Convulsions,Sensitivity to light, Extreme weakness
Antimicrobial Treatment:Thereare no specific medications or therapies to rid your body of an arbovirus.
Treatment involvescarefulmonitoring and symptom relief. Get plenty of rest and drink lots of fluids to
avoid dehydration. If your feverrises or yoursymptoms get worse, seek medical attention. Dependingon
which vimonitor your blood pressure,heart rate, temperature, and respiration
Nursing Intervention
>Pain Management: Alleviation of pain or a reduction in pain to a level of comfort that is acceptable to the
patient
>Analgesic Administration: Use of pharmacologic agents to reduceor eliminate pain
>EnvironmentalManagement: Comfort: Manipulation of the patient’s surroundingsfor promotion of
optimal comfort
>Anxiety Reduction: Minimizing apprehension,dread,foreboding,or uneasiness related to an
unidentified sourceor anticipated danger
>Provision of a modified environmentfor the patient who is experiencing a chronicconfusionalstate
>Calming Technique: Reducinganxiety in patient experiencing acute distress
>Delusion Management: Promoting the comfort, safety, and reality orientation of a patient experiencing
false, fixed beliefs that have little or no basis in realityEnvironmentalManagement: Safety: Manipulation
of the patient’s surroundingsfortherapeutic benefi
>TemperatureRegulation: Attaining and/ormaintaining body temperature within a normal range
>Fever Treatment: Management of a patient with hyperpyrexiacaused by nonenvironmentalfactors
>Nutrition Management: Assisting with or providinga balanced dietary intake of foods and fluid
>Weight Gain Assistance: Facilitating gain of body weight
>Eating DisordersManagement: Prevention and treatment of severediet restrictions and over exercising
or binging and purging of foods and fluids
FUNGAL DISEASES
Cryptococcus Meningitis
CRYPTOCOCCUS NEOFORMANS MENINGITIS
Causative Agent: Cryptococcosis is the
infection caused by the
telemorphic fungi calledCryptococcus.
They form spherical cells, resembling
yeasts, reproduce by duding, and
produce extremely heavy polysaccharide
capsules.
Mode of transmission:aerosolization
and inhalation, in which the infectious
yeast particles become airborne and
then are inhaled by the host and
penetrate in to small airways
Pathophysiology:Cryptococcosis is acquired by inhalation and thus typically affects the lungs.
Many patients present with asymptomatic, self-limited primary lung lesions. In
immunocompetentpatients, the isolated pulmonary lesions usually heal spontaneously without
disseminating, even without antifungal therapy. After inhalation, Cryptococcus may
disseminate, frequently to the brain and meninges, typically manifesting as microscopic
multifocal intracerebral lesions. Meningeal granulomas and larger focal brain lesions may be
evident. Although pulmonary involvement is rarely dangerous, cryptococcal meningitis is life
threatening and requires aggressivetherapy.
PresentingSignsand symptoms:abdominal pain and swelling; nausea; loss of appetite;
unintentional weight loss; weakness/fatigue; confusion; headache; fever; sweating; swollen
glands; blurred vision; bleeding into the skin/rash; bruising; nerve pain/numbness/tingling;
chest pain, tenderness of the sternum, and bone pain .
AntimicrobialTreatment:Suramin,pentamidine
PRIONS DISEASES
Creutzfeldt-Jakob Disease
CREUTZFELDT-JAKOB DISEASE
CausativeAgent:It belongs to a group of diseases
called Transmissible Spongiform Encephalopathies
(TSEs) that affect humans and other animals. TSEs
are thought to be caused by the buildup of an
abnormal, transmissible protein called 'prion' in the
brain.
Mode of transmission: Familial CJD is caused by an
inherited abnormal gene.IatrogenicCJD is
transmitted during medical or surgical procedures,
e.g. human tissue/organ transplant.VariantCJD
(vCJD) is linked to the consumption of food products
from cattle infected with a type of TSE called Bovine
Spongiform Encephalopathy (BSE, commonly known
as 'Mad Cow Disease'). There were also overseas
vCJD cases associated with blood transfusion.
Pathophysiology: the prion crosses the blood brain barrier and deposited
in brain tissue and causes degeneration of the brain tissue. Cell death
occurs and spongyform changes are produced in the brain.
PresentingSigns and Symptoms: Creutzfeldt-Jakob disease is marked by
rapid mental deterioration, usually within a few months. Initial signs and
symptoms typically include: Personality changes, Anxiety,Depression,
Memory loss, Impaired thinking, Blurred vision or blindness, Insomnia,
Difficulty speaking, Difficulty swallowing, Sudden, jerky movements
ANTIMICROBIAL TREATMENT:Currently,there is no cure for Creutzfeldt-Jakob disease (CJD). Researchers
have tested many drugs, including acyclovir, amantidine, antibiotics, antiviral agents, interferon and
steroids. Treatment is aimed at alleviating symptoms and making the patient as comfortable as possible.
Drugs can help relieve pain if it occurs.The drugs clonazepam and sodium valproate may help relieve
myoclonus or irregular, jerking movements.
NURSING INTERVENTION:
>Minimize touching, turning and movement
>Promote a calm, quiet approach and create a quiet environment>Relax the muscles using
benzodiazepines.
>Careful planning to reducethe need for touching the person
>Controlling environmentalactivity and noise.
>Provide or encourage to use of sort lighting.
>Encourageverbalization of feelings
>Perform daily activities optimally
>Encouragethe family to monitor the daily activities.

More Related Content

Similar to microbial disease of CNS.pdf and others for

Cns Infxs
Cns InfxsCns Infxs
Cns Infxs
mycomic
 
Brain Infxn 71609
Brain Infxn 71609Brain Infxn 71609
Brain Infxn 71609
mycomic
 

Similar to microbial disease of CNS.pdf and others for (20)

Tb -copy
Tb  -copyTb  -copy
Tb -copy
 
Infectious diseases
Infectious diseasesInfectious diseases
Infectious diseases
 
Meningitis ppt
Meningitis pptMeningitis ppt
Meningitis ppt
 
ATYPICAL MYCOBACTERIAL INFECTIONS AND THEIR MANIFESTATIONS
ATYPICAL MYCOBACTERIAL INFECTIONS AND THEIR MANIFESTATIONSATYPICAL MYCOBACTERIAL INFECTIONS AND THEIR MANIFESTATIONS
ATYPICAL MYCOBACTERIAL INFECTIONS AND THEIR MANIFESTATIONS
 
Meningitis
MeningitisMeningitis
Meningitis
 
Infectious dermatoses
Infectious dermatosesInfectious dermatoses
Infectious dermatoses
 
neuro infectious diseases.pptx
neuro infectious diseases.pptxneuro infectious diseases.pptx
neuro infectious diseases.pptx
 
Puncture wounds and bites
Puncture wounds and bitesPuncture wounds and bites
Puncture wounds and bites
 
GROUP NO 1 PPT.pptx
GROUP NO 1 PPT.pptxGROUP NO 1 PPT.pptx
GROUP NO 1 PPT.pptx
 
P10.cns infec
P10.cns infecP10.cns infec
P10.cns infec
 
CNS infections
CNS infectionsCNS infections
CNS infections
 
Bacterial meningitis
Bacterial meningitisBacterial meningitis
Bacterial meningitis
 
12 PRINCIPLES OF ANTIBIOTIC THERAPY seminar 12.pptx
12 PRINCIPLES OF ANTIBIOTIC THERAPY seminar 12.pptx12 PRINCIPLES OF ANTIBIOTIC THERAPY seminar 12.pptx
12 PRINCIPLES OF ANTIBIOTIC THERAPY seminar 12.pptx
 
Presentation nursing.pptx VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
Presentation nursing.pptx VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVPresentation nursing.pptx VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
Presentation nursing.pptx VVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVVV
 
Meningitis and its management
Meningitis and its managementMeningitis and its management
Meningitis and its management
 
non infectious meningitis
non infectious meningitisnon infectious meningitis
non infectious meningitis
 
Cns
CnsCns
Cns
 
CELLULITIS superficial bacterial infection.pptx
CELLULITIS  superficial bacterial infection.pptxCELLULITIS  superficial bacterial infection.pptx
CELLULITIS superficial bacterial infection.pptx
 
Cns Infxs
Cns InfxsCns Infxs
Cns Infxs
 
Brain Infxn 71609
Brain Infxn 71609Brain Infxn 71609
Brain Infxn 71609
 

Recently uploaded

Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
AADYARAJPANDEY1
 
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdfPests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
PirithiRaju
 
THYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursingTHYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursing
Jocelyn Atis
 
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Sérgio Sacani
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
muralinath2
 
Jet reorientation in central galaxies of clusters and groups: insights from V...
Jet reorientation in central galaxies of clusters and groups: insights from V...Jet reorientation in central galaxies of clusters and groups: insights from V...
Jet reorientation in central galaxies of clusters and groups: insights from V...
Sérgio Sacani
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
Michel Dumontier
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
muralinath2
 
Seminar on Halal AGriculture and Fisheries.pptx
Seminar on Halal AGriculture and Fisheries.pptxSeminar on Halal AGriculture and Fisheries.pptx
Seminar on Halal AGriculture and Fisheries.pptx
RUDYLUMAPINET2
 

Recently uploaded (20)

Cancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate PathwayCancer cell metabolism: special Reference to Lactate Pathway
Cancer cell metabolism: special Reference to Lactate Pathway
 
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdfPests of sugarcane_Binomics_IPM_Dr.UPR.pdf
Pests of sugarcane_Binomics_IPM_Dr.UPR.pdf
 
Shuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptxShuaib Y-basedComprehensive mahmudj.pptx
Shuaib Y-basedComprehensive mahmudj.pptx
 
GBSN - Microbiology (Lab 2) Compound Microscope
GBSN - Microbiology (Lab 2) Compound MicroscopeGBSN - Microbiology (Lab 2) Compound Microscope
GBSN - Microbiology (Lab 2) Compound Microscope
 
THYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursingTHYROID-PARATHYROID medical surgical nursing
THYROID-PARATHYROID medical surgical nursing
 
GBSN - Microbiology (Lab 1) Microbiology Lab Safety Procedures
GBSN -  Microbiology (Lab  1) Microbiology Lab Safety ProceduresGBSN -  Microbiology (Lab  1) Microbiology Lab Safety Procedures
GBSN - Microbiology (Lab 1) Microbiology Lab Safety Procedures
 
SAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniquesSAMPLING.pptx for analystical chemistry sample techniques
SAMPLING.pptx for analystical chemistry sample techniques
 
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
Gliese 12 b: A Temperate Earth-sized Planet at 12 pc Ideal for Atmospheric Tr...
 
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
Circulatory system_ Laplace law. Ohms law.reynaults law,baro-chemo-receptors-...
 
NuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final versionNuGOweek 2024 Ghent - programme - final version
NuGOweek 2024 Ghent - programme - final version
 
A Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on EarthA Giant Impact Origin for the First Subduction on Earth
A Giant Impact Origin for the First Subduction on Earth
 
Erythropoiesis- Dr.E. Muralinath-C Kalyan
Erythropoiesis- Dr.E. Muralinath-C KalyanErythropoiesis- Dr.E. Muralinath-C Kalyan
Erythropoiesis- Dr.E. Muralinath-C Kalyan
 
Jet reorientation in central galaxies of clusters and groups: insights from V...
Jet reorientation in central galaxies of clusters and groups: insights from V...Jet reorientation in central galaxies of clusters and groups: insights from V...
Jet reorientation in central galaxies of clusters and groups: insights from V...
 
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
Gliese 12 b, a temperate Earth-sized planet at 12 parsecs discovered with TES...
 
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdfSCHIZOPHRENIA Disorder/ Brain Disorder.pdf
SCHIZOPHRENIA Disorder/ Brain Disorder.pdf
 
Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...Multi-source connectivity as the driver of solar wind variability in the heli...
Multi-source connectivity as the driver of solar wind variability in the heli...
 
NuGOweek 2024 full programme - hosted by Ghent University
NuGOweek 2024 full programme - hosted by Ghent UniversityNuGOweek 2024 full programme - hosted by Ghent University
NuGOweek 2024 full programme - hosted by Ghent University
 
FAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable PredictionsFAIR & AI Ready KGs for Explainable Predictions
FAIR & AI Ready KGs for Explainable Predictions
 
Anemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditionsAnemia_ different types_causes_ conditions
Anemia_ different types_causes_ conditions
 
Seminar on Halal AGriculture and Fisheries.pptx
Seminar on Halal AGriculture and Fisheries.pptxSeminar on Halal AGriculture and Fisheries.pptx
Seminar on Halal AGriculture and Fisheries.pptx
 

microbial disease of CNS.pdf and others for

  • 1. MICROBIAL DISEASE OF THE CENTRAL NERVOUS SYSTMEM
  • 2. CENTRAL NERVOUS SYSTEM • The Central Nervous System (CNS) consists of the brain, which protected by the skull bones, and the spinal cord, which is protected by the backbone. • The CNS is covered by three layer of membranes called meninges: the dura mater, arachnoid mater, and pia mater. Cerebrospinal fluid (CSF) circulates between the arachnoid mater and pia mater in the subarachnoid space. • Microorganisms can enter the CNS through trauma, along peripheral nerves, and through the bloodstream and lymhatic system
  • 4. BACTERIAL MENINGITIS a. Haemophilus influenzae Meningitis Causative Agent: Haemophilus influnzae- an aerobic, gram negative bacteria that is a common member of the normal throat microbiota. Mode of transmission: transmitted from person to person through respiratory droplet spread. It may also be rarely acquired through contact with infected respiratory discharge.
  • 5. Pathophysiology:The bacterial organisms replicate and undergo lysis in the CSF, releasing endotoxin or cell wall fragment. These substances initiate the release of inflammatory mediators, which set the stagefor a complex but coordinated sequence of events by which neutrophils binds to cerebral endothelial cells by the release of toxic oxygen products, permitting fluid to move across the capillary wall Presenting signs and symptoms: a triad fever, chills, headache, stiff neck, nausea and vomiting. Eventually meningitis progress to convulsion and coma. AntimicrobialTreatment:Broad spectrum third generation cephalosporins are usually the first choice of antibiotics; some experts recommend including vancomycin NursingIntervention: >Rapid IV fluid replacement >Protect the patient from injury secondary to seizure activity or altered level of consciousness >Reduce high fever to decrease load of the heart and brain from oxygen demand > Maintain head or neck in midline position, provide small pillow to support
  • 6. BACTERIAL MENINGITIS B. Neisseria Meningitis(MeningococcalMeningitis) CausativeAgent:Nesseria meningitides- an aerobic, gram negative bacterium with a polysaccharidecapsule that is importantto its virulence. Mode of transmission: transmitted from person to person through droplets of respiratory or throat secretion from carriers. Pathophysiology: A bacterium penetrates the blood brain barrier. Endotoxin binds to plasma endotoxin binding protein and to the cellular receptor, CD14 and other cellular receptors triggering an intense inflammatory response. Activated macrophagesproduce a rangeof proinflammatorycytokines the concentration of severity of disease.
  • 7. Presenting Signs and Symptoms: stiff neck, high fever, sensitivity to light, confusion, headache, and vomiting. Antimicrobial treatment: Range of antibiotics can treat the infection, including penicillin, ampicillin, and ceftriaxone. Nursing Interventon: >Monitor daily body weigh >Initiate seizure precautions >Elevate the head of the bed 30 degrees, and avoid neck flexion and extreme hip flexion >Rapid IV replacement
  • 8. BACTERIAL MENINGITIS C. Streptococcus pneumonie Meningitis Causative Agent: Streptococcus pneumonie- gram positive, encapsulated diplococcus. Mode of transmission: transmitted through direct contact with tiny droplets from an infected person’smouth, throat or nose. Pathophysiology: during the invasive disease, pneumococcal epithelial adhesion is followed by bloodstream invasion and activation of the complement and coagulation systems. The release of inflammatory mediators facilitates pnemococcal crossing of the blood barrier into the brain, where the bacteria multiply freely and triggered activation of circulating antigen presenting cell and resident microglial cell. The resulting massive inflammation leads to further neutrophil recruitment and inflammation, resulting in the well-known features of bacterial meningitis.
  • 9. PresentingSignsand Symptoms: Fever, drowsiness, impaired consciousness, severe headache, vomiting, stiff neck and pain moving the neck AntimicrobialTreatment: Dexamethasone has been shown to be beneficial as adjunct therapy in the treatment of pneumococcal meningitis if administered 15 to 20 minutes before the first dose of antibiotic and every 6 hours for the next 4 days.research suggestthat dexamethasone improves the outcome in adults and does not increase the risk for gastrointestinalbleeding. NursingIntervention: >Ensuring close neurologic monitoring >Encourage patient to stay hydrated either orally or peripherally >Protect the patient from injury secondary to seizure activity or altered level of consciousness >Assisting getting rest in a quiet, darkened room >Monitoring daily body weight; serum electrolytes; and urine volume, specific gravity and osmolality; especially if syndrome of inappropriateantidiuretic hormone is suspected.
  • 10. TETANUS Causative Agent: Clostridum tetani obligately anaerobic, endospore forming, gram positive rod. It is especially common in soil contaminated with animal fecal waste. advance case of tetanus Mode of transmission: spores get into the body through broken skin, usually through injuries from contaminated objects. Certain breaks in the skin are more likely to get infected with tetanus bacteria.
  • 11. Pathophysiology:when tetanus toxin is taken up into nerve terminals of lower motor neurons, the nerve cells that activatevoluntary muscle. Tetanus toxin is a zinc metalloproteinasethat targetprotein that is necessary for the release of neurotransmitter from nerve endings through fusion of synaptic vesicles with the neuronal plasma membrane. The initial symptoms of local tetanus infection may therefore flaccid paralysis, caused by interference with vesicular release of acetylcholine at the neuromuscular junction, as occur in butulinum toxin. However, unlike botulinum toxin, tetanus toxin undergoes extensive retrogradetransport in axons of lower motor neurons and thus reaches the spinal cord or brainstem. Here the toxin is transported across synapses and taken up by nerve endings ihibitiory GABA ergic and gylnergic neurons that control the activity of the lower neurons. Once inside inhibitory nerve terminals, tetanus toxn cleaves VAMP,thereby inhibiting the release GABA and glycine. The result is a partial, functional denervation of the lower motor neurons which lead to their hyperactivity and to increased muscle activity and in the form of rigidity and spasms. PresentingSignsand Symptoms:Spasms and stiffness in your jaw muscles, stiffness in the neck muscles, difficulty swallowing, Fever, Elevating Blood pPressure and rapid heart rate.
  • 12. Antimicrobial Treatment:Administer Human TIG 500 units by intramuscular injection or intravenously as soon as possible; in addition administer age appropriate TT-containingvaccine, 0.5 cc by intramuscular injection. Metronidole is preferred,penicillin G, tertracyclines, macrolides, clindamycin, cephalosporins and chloramphenicol are also effective; Nursing Intervention: >Protect the client from injury >Monitor for signs and symptoms of arrhythmias >Preventclient from having spasms by: -controllingthe environment -avoiding stress, pain, coughing or flatus to ccur in patient -avoid touching, turning and jarring the bed of the client >Maintain adequate airway and ventillation
  • 13. LEPROSY Causative Agent: Mycobacterium leprae the first bacterium to be identified as causing disease in humans. Mode of Transmission: spread person to person by nasal secretions or droplets. They speculate that infected droplets reach other peoples' nasal passages and begin the infection there.
  • 14. Pathophysiology:microorganismthat has a predilection for the skin and nerves. M. leprae primarily infects Schwann cells in the peripheral nerves leading to nerve damageand the development of disabilities. Despite reduced prevalenceof M. leprae infection in the endemic countries following implementation of multidrug therapy (MDT) program by WHO to treat leprosy, new case detection rates are still high-indicating active transmission. The susceptibility to the mycobacteria and the clinical course of the disease are attributed to the host immune response, which heralds the review of immunopathology of this complex disease. PresentingSignand Symptoms:Early symptoms begin in cooler areas of the body and include loss of sensation. Signs of leprosy are painless ulcers, skin lesions of hypopigmented macules (flat, pale areas of skin) , and eye damage(dryness, reduced blinking). AntimicrobialTreatment:The first-line drugs are dapsone, rifampin, and clofazimine. ... Second- line agents include minocycline, ofloxacin, and clarithromycin,which can be used to treat a single skin lesion or to treat patients with dapsone allergy.
  • 15. Nursing Intervention >Diagnose the impaired tissue integrity and monitor the characteristics of the lesion such as size, color, odor and drainage. >Clean the wounds with saline or nontoxic substances as indicated. >Apply sterile bandage to cover the wounds and maintain aseptic technique >Examine the wound damage daily during each dressing changes. ⦁ Routinely monitor temperature and color of skin.
  • 17. POLIOMYELITIS Causative Agent: human enterovirus and member of the family of Picornaviridae. Mode of transmission: Polio viruses are spread predominantly by the fecal–oral route.
  • 18. Pathophysiology:The virus enters via the fecal-oral or respiratory route, then enters the lymphoid tissues of the GI tract. A primary (minor) viremia follows with spread of virus to the reticuloendothelial system. Infection may be contained at this point, or the virus may further multiply and cause several days of secondary viremia, culminating in the development of symptoms and antibodies. In paralytic infections, poliovirus enters the CNS—whether via secondary viremia or via migration up peripheral nerves is unclear. Significant damageoccurs in only the spinal cord and brain, particularly in the nerves controlling motor and autonomic function. Inflammation compounds the damageproduced by primary viral invasion. Factors predisposing to serious neurologic damageinclude Increasingage (throughout life),Recent tonsillectomy or intramuscular injection, pregnancy,impairment of B-cell function, and physical exertion concurrentwith onset of the CNS phase. PRESENTING SIGN AND SYMPTOMS: which can last up to 10 days, include fever, sore throat, headache, vomiting, fatigue, back pain or stiffness, neck pain, stiffness in the arms or legs, muscle weakness or tenderness
  • 19. ANTIMICROBIAL TREATMENTS:No drug can kill the virus once an infection has begun. Treatment is directed at controllingthe symptoms of the disease. People with minor poliomyelitis are treated with bed rest and over-the-counter medicines to control fever and muscle aches. People with major poliomyelitis may requireadditional treatments, including Physical therapy, Measures to preventurinary tract infections, Mechanical breathing support NURSING INTERVETION: >Maintain a patent airway, and keep a tracheotomy tray at the patient’s bed side. >Encouragea return to mild activity as soon as possible. >Preventfecal impaction by giving enough fluids to ensurean adequate daily urine output of low specific gravity. >Provide good skin care, re-position the patient often, and keep bed linens dry. >To alleviate discomforts, use foam rubberpads and sandbags or light splints as ordered. >Wash hands thoroughly after contact with the patient or any of his secretions and excretions.
  • 20. RABIES Causative Agent: Rabies virus, a member of genus lyssavirus having a characteristic of bullet shape. Lyssavirus are single stranded RNA viruses with no proofreading capability and mutant strains develop rapidly. Mode of Transmission: The most common mode of rabies virus transmissionis through the bite and virus-containing saliva of an infected host. Though transmission has been rarely documented via other routes such as contamination of mucous membranes (i.e., eyes, nose, mouth), aerosoltransmission, and corneal and organ transplantations.
  • 21. PresentingSignand Symptoms: Paresthesia, pain, or intense itching at the inoculation site is pathognomonic for rabies and occurs in 50% of cases during this phase; this may be the individual's only presenting sign. Symptoms may include the following: Malaise. AntimicrobialTreatment: Rabies shots include: A fast-acting shot (rabies immune globulin) to prevent the virus from infecting you. Part of this injection is given near the area where the animal bit you if possible, as soon as possible after the bite. NursingIntervention: >Isolate the patient >Give emotional and spiritual support >Darken the room and prove a quiet environment >Patient should not be bathed and there should not be any running water in the room or within the hearing distance of the patient. >If IV fluid has to be given it should be wrapped and needle should be securely anchored in the vein to avoid dislodging in times of restlessness
  • 22. ARBOVIRAL ENCEPHALITIS CausativeAgent: Arthropod-borne viruses (arboviruses) are of paramount concern as a group of pathogens at the forefront of emerging and re- emerging diseases. Here, we discuss arboviruses from diverse families (Flaviviruses, Alphaviruses, and the Bunyaviridae) that are causativeagents of encephalitis in humans Mode of Transmission: Arboviral encephalitis: Inflammation of the brain (encephalitis) caused by infection with an arbovirus, a virus transmitted by a mosquito, tick or another arthropod. Infection of vertebrates, including humans, occurs when an infected arthropod feasts upon them for a blood meal.
  • 23. Pathophysiology: Arthropod-borneviruses(arboviruses) are of paramount concern as a group of pathogens at the forefrontof emerging and re-emerging diseases. Although some arboviral infections are asymptomatic or presentwith a mild influenza-like illness, many are important human and veterinary pathogens causing serious illness ranging fromrash and arthritis to encephalitis and hemorrhagic fever. Here, we discuss arbovirusesfrom diverse families (Flaviviruses, Alphaviruses, and the Bunyaviridae) that are causative agents of encephalitis in humans. An understandingof the natural history of these infections as well as shared mechanisms of neuroinvasion and neurovirulenceis critical to controlthe spread of these viruses and for the developmentof effective vaccines and treatment modalities. Presenting Sign and Symptoms:Headache, Feeling unwell, Drowsiness,Fever,Vomiting, Stiff neck, Muscle sorenessor trembling, Confusion,Convulsions,Sensitivity to light, Extreme weakness Antimicrobial Treatment:Thereare no specific medications or therapies to rid your body of an arbovirus. Treatment involvescarefulmonitoring and symptom relief. Get plenty of rest and drink lots of fluids to avoid dehydration. If your feverrises or yoursymptoms get worse, seek medical attention. Dependingon which vimonitor your blood pressure,heart rate, temperature, and respiration Nursing Intervention >Pain Management: Alleviation of pain or a reduction in pain to a level of comfort that is acceptable to the patient >Analgesic Administration: Use of pharmacologic agents to reduceor eliminate pain
  • 24. >EnvironmentalManagement: Comfort: Manipulation of the patient’s surroundingsfor promotion of optimal comfort >Anxiety Reduction: Minimizing apprehension,dread,foreboding,or uneasiness related to an unidentified sourceor anticipated danger >Provision of a modified environmentfor the patient who is experiencing a chronicconfusionalstate >Calming Technique: Reducinganxiety in patient experiencing acute distress >Delusion Management: Promoting the comfort, safety, and reality orientation of a patient experiencing false, fixed beliefs that have little or no basis in realityEnvironmentalManagement: Safety: Manipulation of the patient’s surroundingsfortherapeutic benefi >TemperatureRegulation: Attaining and/ormaintaining body temperature within a normal range >Fever Treatment: Management of a patient with hyperpyrexiacaused by nonenvironmentalfactors >Nutrition Management: Assisting with or providinga balanced dietary intake of foods and fluid >Weight Gain Assistance: Facilitating gain of body weight >Eating DisordersManagement: Prevention and treatment of severediet restrictions and over exercising or binging and purging of foods and fluids
  • 26. CRYPTOCOCCUS NEOFORMANS MENINGITIS Causative Agent: Cryptococcosis is the infection caused by the telemorphic fungi calledCryptococcus. They form spherical cells, resembling yeasts, reproduce by duding, and produce extremely heavy polysaccharide capsules. Mode of transmission:aerosolization and inhalation, in which the infectious yeast particles become airborne and then are inhaled by the host and penetrate in to small airways
  • 27. Pathophysiology:Cryptococcosis is acquired by inhalation and thus typically affects the lungs. Many patients present with asymptomatic, self-limited primary lung lesions. In immunocompetentpatients, the isolated pulmonary lesions usually heal spontaneously without disseminating, even without antifungal therapy. After inhalation, Cryptococcus may disseminate, frequently to the brain and meninges, typically manifesting as microscopic multifocal intracerebral lesions. Meningeal granulomas and larger focal brain lesions may be evident. Although pulmonary involvement is rarely dangerous, cryptococcal meningitis is life threatening and requires aggressivetherapy. PresentingSignsand symptoms:abdominal pain and swelling; nausea; loss of appetite; unintentional weight loss; weakness/fatigue; confusion; headache; fever; sweating; swollen glands; blurred vision; bleeding into the skin/rash; bruising; nerve pain/numbness/tingling; chest pain, tenderness of the sternum, and bone pain . AntimicrobialTreatment:Suramin,pentamidine
  • 29. CREUTZFELDT-JAKOB DISEASE CausativeAgent:It belongs to a group of diseases called Transmissible Spongiform Encephalopathies (TSEs) that affect humans and other animals. TSEs are thought to be caused by the buildup of an abnormal, transmissible protein called 'prion' in the brain. Mode of transmission: Familial CJD is caused by an inherited abnormal gene.IatrogenicCJD is transmitted during medical or surgical procedures, e.g. human tissue/organ transplant.VariantCJD (vCJD) is linked to the consumption of food products from cattle infected with a type of TSE called Bovine Spongiform Encephalopathy (BSE, commonly known as 'Mad Cow Disease'). There were also overseas vCJD cases associated with blood transfusion.
  • 30. Pathophysiology: the prion crosses the blood brain barrier and deposited in brain tissue and causes degeneration of the brain tissue. Cell death occurs and spongyform changes are produced in the brain. PresentingSigns and Symptoms: Creutzfeldt-Jakob disease is marked by rapid mental deterioration, usually within a few months. Initial signs and symptoms typically include: Personality changes, Anxiety,Depression, Memory loss, Impaired thinking, Blurred vision or blindness, Insomnia, Difficulty speaking, Difficulty swallowing, Sudden, jerky movements
  • 31. ANTIMICROBIAL TREATMENT:Currently,there is no cure for Creutzfeldt-Jakob disease (CJD). Researchers have tested many drugs, including acyclovir, amantidine, antibiotics, antiviral agents, interferon and steroids. Treatment is aimed at alleviating symptoms and making the patient as comfortable as possible. Drugs can help relieve pain if it occurs.The drugs clonazepam and sodium valproate may help relieve myoclonus or irregular, jerking movements. NURSING INTERVENTION: >Minimize touching, turning and movement >Promote a calm, quiet approach and create a quiet environment>Relax the muscles using benzodiazepines. >Careful planning to reducethe need for touching the person >Controlling environmentalactivity and noise. >Provide or encourage to use of sort lighting. >Encourageverbalization of feelings >Perform daily activities optimally >Encouragethe family to monitor the daily activities.